Talus Bioscience
Business Services · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
550 17th Ave Ste 550, Seattle, Washingto...Phone Number
(206) 487-1062Website
talus.bioRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About Talus Bioscience
Talus Bioscience is a drug discovery company founded by a world-class team of scientific leaders in proteomics, biochemistry, and machine learning.Explore more
Talus Bioscience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Talus Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Talus Bioscience has new funding data
Website visits: Recent activity has been detected on your website
Check if Talus Bioscience has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Talus Bioscience recently announced quarterly report
Click to see if Talus Bioscience had a recent Job posting/layoffs
Check out if Talus Bioscience is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Talus Bioscience
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Talus Bioscience launches new products
Talus Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Talus Bioscience as Masked Content
Find 2 more new buyers
Compare Similar Companies to Talus Bioscience
Compare insights from companies similar to Talus Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Talus Bioscience is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Talus Bioscience is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Talus Bioscience.
Talus Bioscience financials insights
Gather financial insights about Talus Bioscience, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Unspecified
$9.8M
2024
Angel/Seed
$11.2M
Talus Bioscience Tech Stack
A closer look at the technologies used by Talus Bioscience
Most Recent Scoops
Person-Based
Event
Product Marketing, Events, Sales, Food & Beverage, Hospitality, Field /Outside Sales, Field Marketing
New Hire
Executive Move
Executive Moves, New Hire
Facilities Relocation / Expansion
Talus Bioscience is planning to move offices in March 2025. The move will impact approximately 8 employees at the existing office located at 550 17Th Ave, Suite #550, Seattle, WA.
Facilities Relocation/Expansion
Funding
Project
Award, Spending/Investment, Application Development, Product Development, Search, Software, Medical Research
Talus Bioscience News & Media
Talus Bio Presents Preclinical Data on Transcription Factor Therapeutic Programs at the AACR Annual Meeting 2025
SEATTLE--(BUSINESS WIRE)--Talus Bioscience, a technology-enabled therapeutics company, today announced new preclinical data from programs targeting transcription factors in chordoma, non-small cell lung cancer, and advanced prostate cancer. The data, presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting, held April 25-30, support Talus Bio’s first-in-class approach to target previously undruggable transcription factors using regulome-scale discovery in live humanTalus Bioscience Announces $11.2M in New Funding Led by Two Bear Capital to Advance AI Platform for Transcription Factor Therapeutic Discovery
SEATTLE--(BUSINESS WIRE)--Talus Bioscience, a drug discovery company founded by a world-class team of scientific leaders in proteomics, biochemistry, and machine learning, today announced $11.2M in new venture funding. The Seed+ round was led by Two Bear Capital, with participation from WRF Capital, NFX, YC Continuity Fund, Funders Club VC, and BoxOne Ventures. The funding will be invested to advance Talus Bio’s therapeutic programs, which include Brachyury-driven cancers and an undruggable traTalus Bioscience lands $4.3M in grant funding for drug discovery platform
Seattle-based biotech startup Talus Bioscience landed $4.3 million in non-dilutive grants to boost development of its drug discovery platform that seeks compounds that affect gene activity. The startup received $2.3 million from Spokane, Wash.-based Andy Hill Cancer Research Endowment (CARE) Fund. It received an additional $2 million from small business innovation research (SBIR), a U.S. government-funded program.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Talus Bioscience
Sign Up For FreeTo access detailed company insights
Talus Bioscience is a drug discovery company founded by a world-class team of scientific leaders in proteomics, biochemistry, and machine learning.... Read More
